After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ARWR belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Arrowhead Pharmaceuticals Inc is $4.02B. A total of 2.7 million shares were traded on the day, compared to an average of 2.17M shares.
In the most recent transaction, Hamilton James C sold 15,000 shares of ARWR for 25.00 per share on Sep 02 ’25. After the transaction, the Chief Medical Officer now owns 247,122 company shares. In a previous transaction on Sep 02 ’25, Hamilton James C bought 15,000 shares at 25.00 per share.
Among the insiders who sold shares, Hamilton James C disposed of 9,389 shares on Aug 15 ’25 at a per-share price of $20.00. This resulted in the Chief Medical Officer holding 262,122 shares of ARWR after the transaction. In another insider transaction, Hamilton James C sold 611 shares at $20.00 per share on Aug 13 ’25. Company shares held by the Chief Medical Officer now total 271,511.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ARWR has a high of $29.34 and a low of $9.57.
As of this writing, ARWR has an earnings estimate of -$0.26 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $0.69 per share and a lower estimate of -$1.18. The company reported an EPS of -$1.37 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ARWR’s latest balance sheet shows that the firm has $367.79M in Cash & Short Term Investments as of fiscal 2021. There were $25.55M in debt and $146.54M in liabilities at the time. Its Book Value Per Share was $3.78, while its Total Shareholder’s Equity was $408.82M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARWR is Buy with a score of 4.27.
